These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2667487)

  • 1. Pharmacological studies on the hypoglycemic effect of 7,8-dihydro-2-(4-methylpiperazinyl)-4-(1-pyrrolidinyl)-6H-thi opyrano [3,2-d] pyrimidine dimaleate (MTP-1307), a novel hypoglycemic agent.
    Kunoh Y; Ogawa H; Nagasaka M; Asai H; Iguchi A; Niki A; Sakamoto N
    Arch Int Pharmacodyn Ther; 1989; 298():276-87. PubMed ID: 2667487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoglycemic activity of MTP-1403 (2-amino-7,8-dihydro-4-piperazinyl-6H-thiopyrano 3,2-d pyrimidine), a new hypoglycemic agent.
    Kunoh Y; Iguchi A; Gotoh M; Nomura T; Shibata M; Sakamoto N
    Arch Int Pharmacodyn Ther; 1986 Apr; 280(2):302-13. PubMed ID: 3521517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoglycemic activities of MTP-3631, a novel thiopyranopyrimidine derivative.
    Ogawa H; Kunoh Y; Sugiura T; Nagasaka M
    Life Sci; 1992; 50(5):375-81. PubMed ID: 1732707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of new hypoglycemic agent 2-piperazinyl-4-methyl-amino-5-methylthieno [2,3-d]pyrimidine dihydrochloride hydrate.
    Fujiwara T; Sakamoto Y; Fukasawa I; Horikoshi H; Sugiyama M; Fukumi H
    Arzneimittelforschung; 1986 Dec; 36(12):1770-4. PubMed ID: 2882759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ciglitazone, a new hypoglycemic agent. II. Effect on glucose and lipid metabolisms and insulin binding in the adipose tissue of C57BL/6J-ob/ob and -+/? mice.
    Chang AY; Wyse BM; Gilchrist BJ
    Diabetes; 1983 Sep; 32(9):839-45. PubMed ID: 6354791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoglycemic effect of isoleucine involves increased muscle glucose uptake and whole body glucose oxidation and decreased hepatic gluconeogenesis.
    Doi M; Yamaoka I; Nakayama M; Sugahara K; Yoshizawa F
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1683-93. PubMed ID: 17299083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic basis for the diabetogenic action of growth hormone in the obese (ob/ob) mouse.
    Cameron CM; Kostyo JL; Adamafio NA; Dunbar JC
    Endocrinology; 1987 Apr; 120(4):1568-75. PubMed ID: 3549265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidiabetic activity of MTP-3115 in normal and diabetic mice.
    Yen TT; Dininger NB; Broderick CL; Gill AM
    Arch Int Pharmacodyn Ther; 1990; 308():137-48. PubMed ID: 2099133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ciglitazone on glucose uptake and insulin sensitivity in skeletal muscle of the obese (ob/ob) mouse: distinct insulin and glucocorticoid effects.
    Shargill NS; Tatoyan A; Fukushima M; Antwi D; Bray GA; Chan TM
    Metabolism; 1986 Jan; 35(1):64-70. PubMed ID: 3510364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfonyliminoimidazolidines, a new class of oral hypoglycemic agents. 3. Hypoglycemic activity and mode of action of 1-[p-[2-(crotonylamino)-ethyl]-phenylsulfonyl]-3-cyclohexyl-2-imino- imidazolidine (CGP 11 112).
    Märki F; Albrecht W; de Gasparo M
    Arzneimittelforschung; 1983; 33(10):1455-63. PubMed ID: 6360181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The hypoglycemic effect of AH-9].
    Jiang Z; Xie M
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Aug; 15(4):235-41. PubMed ID: 8168201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative contribution of glycogenolysis and gluconeogenesis to hepatic glucose production in control and diabetic rats. A re-examination in the presence of euglycaemia.
    Giaccari A; Morviducci L; Pastore L; Zorretta D; Sbraccia P; Maroccia E; Buongiorno A; Tamburrano G
    Diabetologia; 1998 Mar; 41(3):307-14. PubMed ID: 9541171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AS1907417, a novel GPR119 agonist, as an insulinotropic and β-cell preservative agent for the treatment of type 2 diabetes.
    Yoshida S; Tanaka H; Oshima H; Yamazaki T; Yonetoku Y; Ohishi T; Matsui T; Shibasaki M
    Biochem Biophys Res Commun; 2010 Oct; 400(4):745-51. PubMed ID: 20816753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of glycogen synthesis by proglycosyn (LY177507) by isolated hepatocytes of normal and streptozotocin diabetic rats.
    Guo ZK; Wals PA; Katz J
    J Biol Chem; 1991 Nov; 266(33):22323-7. PubMed ID: 1939254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 1-[4- [2-(4-bromobenzenesulfonamino) ethyl] phenylsulfonyl]-3-(trans-4-methylcyclohexyl)urea (I4), a new synthetic sulfonylurea compound, on glucose metabolism in vivo and in vitro.
    Wu GZ; Hong G; Zhang WP; Zhang HB
    Arzneimittelforschung; 2009; 59(11):550-6. PubMed ID: 20066963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TMG-123, a novel glucokinase activator, exerts durable effects on hyperglycemia without increasing triglyceride in diabetic animal models.
    Tsumura Y; Tsushima Y; Tamura A; Hasebe M; Kanou M; Kato H; Kobayashi T
    PLoS One; 2017; 12(2):e0172252. PubMed ID: 28207836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a new hypoglycemic agent (MDL-310) on glucose metabolism.
    Robinson KM; Payne AJ; Zehr SL; Rhinehart BL
    J Pharmacol Exp Ther; 1985 Dec; 235(3):571-6. PubMed ID: 3841154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilization in a non-obese type 2 diabetes Goto-Kakizaki rats.
    Yoshida T; Okuno A; Tanaka J; Takahashi K; Nakashima R; Kanda S; Ogawa J; Hagisawa Y; Fujiwara T
    Eur J Pharmacol; 2009 Nov; 623(1-3):141-7. PubMed ID: 19765581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-hyperglycaemic action of BRL 26830, a novel beta-adrenoceptor agonist, in mice and rats.
    Sennitt MV; Arch JR; Levy AL; Simson DL; Smith SA; Cawthorne MA
    Biochem Pharmacol; 1985 Apr; 34(8):1279-85. PubMed ID: 2859857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals.
    Ikeda H; Taketomi S; Sugiyama Y; Shimura Y; Sohda T; Meguro K; Fujita T
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):156-62. PubMed ID: 2334455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.